当前位置:首页 - 行情中心 - 佰仁医疗(688198) - 财务分析 - 现金流量表

佰仁医疗

(688198)

  

流通市值:93.79亿  总市值:93.79亿
流通股本:1.38亿   总股本:1.38亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金312,731,048.08168,673,464.87643,576,394.11428,045,257.95
  收到其他与经营活动有关的现金12,650,734.213,131,383.3728,545,681.9125,066,359.93
  经营活动现金流入小计325,381,782.29171,804,848.24672,122,076.02453,111,617.88
  购买商品、接受劳务支付的现金28,710,316.329,365,171.5540,855,610.6931,046,209.51
  支付给职工以及为职工支付的现金113,906,518.0159,648,996.32172,686,800.21122,207,975.99
  支付的各项税费80,558,114.4952,809,070.2474,862,543.0357,253,128.34
  支付其他与经营活动有关的现金101,711,681.1838,537,332.4185,924,092.42142,717,360.37
  经营活动现金流出小计324,886,630160,360,570.51474,329,046.35353,224,674.21
  经营活动产生的现金流量净额495,152.2911,444,277.73197,793,029.6799,886,943.67
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,338,020.561,050,912.3211,034,164.6610,921,895.26
  处置固定资产、无形资产和其他长期资产收回的现金净额80,00020,0001,024.171,026.29
  收到的其他与投资活动有关的现金691,519,191.2328,726,079.05943,000,000821,200,000
  投资活动现金流入小计693,937,211.76329,796,991.37954,035,188.83832,122,921.55
  购建固定资产、无形资产和其他长期资产支付的现金62,909,311.3538,203,786.99136,196,463.77103,960,911.4
  投资支付的现金15,000,00015,000,00018,000,000-
  支付其他与投资活动有关的现金432,940,000221,059,669.54978,600,001831,800,000
  投资活动现金流出小计510,849,311.35274,263,456.531,132,796,464.77935,760,911.4
  投资活动产生的现金流量净额183,087,900.4155,533,534.84-178,761,275.94-103,637,989.85
三、筹资活动产生的现金流量:
  吸收投资收到的现金--5,333,603.355,333,603.35
  取得借款收到的现金31,000,000-75,000,00075,000,000
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计31,000,000-80,333,603.3580,333,603.35
  偿还债务支付的现金65,000,00025,000,000--
  分配股利、利润或偿付利息支付的现金111,070,000.52537,473.55110,837,760.05110,433,947.55
  支付其他与筹资活动有关的现金9,689,382.59263,948.744,675,208.962,958,979.57
  筹资活动现金流出小计185,759,383.1125,801,422.29115,512,969.01113,392,927.12
  筹资活动产生的现金流量净额-154,759,383.11-25,801,422.29-35,179,365.66-33,059,323.77
四、汇率变动对现金及现金等价物的影响-155,850.69-49,856.45-142,375.25-114,344.48
五、现金及现金等价物净增加额28,667,818.941,126,533.83-16,289,987.18-36,924,714.43
  加:期初现金及现金等价物余额39,259,820.0739,259,820.0755,549,807.2555,549,807.25
  期末现金及现金等价物余额67,927,638.9780,386,353.939,259,820.0718,625,092.82
补充资料:
  净利润42,250,525.44-179,682,344.8-
  固定资产和投资性房地产折旧15,169,199.39-27,884,353.98-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,169,199.39-27,884,353.98-
  无形资产摊销4,814,876.63-10,252,265.75-
  长期待摊费用摊销1,587,580.02-3,555,588.95-
  处置固定资产、无形资产和其他长期资产的损失56,219.57--1,765.08-
  固定资产报废损失9,873.3-3,729-
  公允价值变动损失-69,289.81--830,305.47-
  财务费用2,948,598.39--85,430.92-
  投资损失-3,547,892.39--7,845,299.96-
  递延所得税-1,196,094.62--2,531,848.94-
  其中:递延所得税资产减少51,400.26--2,566,656.09-
    递延所得税负债增加-1,247,494.88-34,807.15-
  存货的减少-23,626,718.93--15,883,478.36-
  经营性应收项目的减少-28,254,250.75--75,270,181.59-
  经营性应付项目的增加-13,263,389.36-72,151,758.02-
  不涉及现金收支的投资和筹资活动金额其他项目--13,147,557.44-
  现金的期末余额67,927,638.97-39,259,820.07-
  减:现金的期初余额39,259,820.07-55,549,807.25-
  现金及现金等价物的净增加额28,667,818.9--16,289,987.18-
公告日期2026-08-272026-04-222026-04-222025-10-31
审计意见(境内)标准无保留意见
TOP↑